Search research articles
Contact Us
Filters
Showing results (51-60 of 71) with videos related to
Page
of 8
Sort By:
Pharmacological Research
|
December 18, 2010
The characterization of microtubule-stabilizing drugs as possible therapeutic agents for Alzheimer's disease and related tauopathies
Kurt R Brunden, Yuemang Yao, Justin S Potuzak, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
March 14, 2023
Hydrogen Bonding Parameters by Rapid Colorimetric Assessment: Evaluation of Structural Components Found in Biological Ligands and Organocatalysts
Hanna F Roenfanz, Thomas J Paniak, Cameron B Berlin, et al.
ACS Pharmacology & Translational Science
|
November 17, 2023
Targeted Reversible Covalent Modification of a Noncatalytic Lysine of the Krev Interaction Trapped 1 Protein Enables Site-Directed Screening for Protein-Protein Interaction Inhibitors
Karol R Francisco, Jessica Bruystens, Carmine Varricchio, et al.
Journal of Medicinal Chemistry
|
March 12, 2016
Structure Property Relationships of Carboxylic Acid Isosteres
Pierrik Lassalas, Bryant Gay, Caroline Lasfargeas, et al.
Journal of Medicinal Chemistry
|
December 4, 2013
Design, synthesis, and biological evaluation of 1-phenylpyrazolo[3,4-e]pyrrolo[3,4-g]indolizine-4,6(1H,5H)-diones as new glycogen synthase kinase-3β inhibitors
Valeria La Pietra, Giuseppe La Regina, Antonio Coluccia, et al.
Human Molecular Genetics
|
November 26, 2015
Altered microtubule dynamics and vesicular transport in mouse and human MeCP2-deficient astrocytes
Chloé Delépine, Hamid Meziane, Juliette Nectoux, et al.
Journal of Medicinal Chemistry
|
July 4, 2014
Brain-penetrant, orally bioavailable microtubule-stabilizing small molecules are potential candidate therapeutics for Alzheimer's disease and related tauopathies
Kevin Lou, Yuemang Yao, Adam T Hoye, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 17, 2012
The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice
Bin Zhang, Jenna Carroll, John Q Trojanowski, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Structure-Activity Relationship and Target Investigation of Thiophen-2-yl-Pyrimidines against <i>Schistosoma</i> species
Karol R Francisco, Bobby Lucero, Darius Yohannan, et al.
Journal of Medicinal Chemistry
|
May 23, 2017
Multitargeted Imidazoles: Potential Therapeutic Leads for Alzheimer's and Other Neurodegenerative Diseases
Anne-Sophie Cornec, Ludovica Monti, Jane Kovalevich, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 71) with videos related to
Sort By:
Page
of 8
Pharmacological Research
|
December 18, 2010
The characterization of microtubule-stabilizing drugs as possible therapeutic agents for Alzheimer's disease and related tauopathies
Kurt R Brunden, Yuemang Yao, Justin S Potuzak, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
March 14, 2023
Hydrogen Bonding Parameters by Rapid Colorimetric Assessment: Evaluation of Structural Components Found in Biological Ligands and Organocatalysts
Hanna F Roenfanz, Thomas J Paniak, Cameron B Berlin, et al.
ACS Pharmacology & Translational Science
|
November 17, 2023
Targeted Reversible Covalent Modification of a Noncatalytic Lysine of the Krev Interaction Trapped 1 Protein Enables Site-Directed Screening for Protein-Protein Interaction Inhibitors
Karol R Francisco, Jessica Bruystens, Carmine Varricchio, et al.
Journal of Medicinal Chemistry
|
March 12, 2016
Structure Property Relationships of Carboxylic Acid Isosteres
Pierrik Lassalas, Bryant Gay, Caroline Lasfargeas, et al.
Journal of Medicinal Chemistry
|
December 4, 2013
Design, synthesis, and biological evaluation of 1-phenylpyrazolo[3,4-e]pyrrolo[3,4-g]indolizine-4,6(1H,5H)-diones as new glycogen synthase kinase-3β inhibitors
Valeria La Pietra, Giuseppe La Regina, Antonio Coluccia, et al.
Human Molecular Genetics
|
November 26, 2015
Altered microtubule dynamics and vesicular transport in mouse and human MeCP2-deficient astrocytes
Chloé Delépine, Hamid Meziane, Juliette Nectoux, et al.
Journal of Medicinal Chemistry
|
July 4, 2014
Brain-penetrant, orally bioavailable microtubule-stabilizing small molecules are potential candidate therapeutics for Alzheimer's disease and related tauopathies
Kevin Lou, Yuemang Yao, Adam T Hoye, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 17, 2012
The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice
Bin Zhang, Jenna Carroll, John Q Trojanowski, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Structure-Activity Relationship and Target Investigation of Thiophen-2-yl-Pyrimidines against <i>Schistosoma</i> species
Karol R Francisco, Bobby Lucero, Darius Yohannan, et al.
Journal of Medicinal Chemistry
|
May 23, 2017
Multitargeted Imidazoles: Potential Therapeutic Leads for Alzheimer's and Other Neurodegenerative Diseases
Anne-Sophie Cornec, Ludovica Monti, Jane Kovalevich, et al.
Page
of 8